Comment on: Safety of penile prosthesis implantation in solid organ transplant recipients: a systematic review
Edoardo Pozzi,Ranjith Ramasamy
DOI: https://doi.org/10.1038/s41443-024-00995-3
2024-11-03
International Journal of Impotence Research
Abstract:The management of erectile dysfunction (ED) in solid organ transplant recipients (SOT) a prevalent yet understudied topic, especially in men who receive a penile prosthesis (PP) [1,2,3]. The clinical message is clear: the quality of life of men who have received a SOT should be taken into account as much as the survival following the SOT itself [4]. As such, one of the issues that impair their quality of life is the onset of ED [1,2,3] even prior to the SOT typically due to multiple comorbidities. Unsurprisingly, the prevalence of ED is much higher in men receiving SOT as compared to their age-matched cohorts [4,5,6]. As survival outcomes for organ transplant recipients continue to improve, addressing ED in men with SOT becomes an important consideration to enhance their quality of life [4]. The comprehensive systematic review conducted by Territo et al. investigates the safety, risks, and outcomes of PP implantation in a morbid patient population [7]. Since the men who receive an organ transplant live in a state of perpetual immunosuppression to prevent organ rejection, it is important to evaluate whether there is an increase in the risk of complications of PP implantation, particularly the infection of the device itself [8,9,10]. Territo et al. identified several studies reporting PP implantation outcomes in organ transplant recipient men [7]. All included studies were of retrospective design, with the majority (57.14%, 8 studies) consisting of single cases or case series. Nonetheless, four studies included case-matched controls [7]. The sample sizes varied considerably, ranging from individual cases to 175 SOT recipients [7]. Furthermore, the included cohorts spanned different timeframes, ranging from 1976 to 2020 [7]. Nevertheless, several key points emerged from this systematic review [7]. First, the studies reviewed showed considerable variation in PP implantation timing relative to SOT, with procedures performed before, after, or even during SOT. The time between SOT and complications spanned a wide range, from as short as 3 weeks to as long as 54 months after the transplant [7]. Inflatable PP was the most commonly used type, with penoscrotal and infra-pubic approaches being the primary surgical techniques [7]. Second, antibiotic prophylaxis practices varied significantly across studies, with some failing to report this crucial information [7]. When reported, the antibiotic regimens differed in type and duration, ranging from cephalosporins alone to combinations with aminoglycosides or quinolones [7]. There is heterogeneity in the analyzed data as antibiotic prophylaxis has been demonstrated to play a crucial role in preventing PP post-operative infections [7]. As such, complications affected 11.15% of patients, with mechanical device failure (5.9%) slightly outpacing infections (4.26%). Most infection cases necessitated hospitalization, intravenous antibiotics, and PP removal, with two severe cases progressing to life-threatening Fournier's gangrene [7]. Mechanical failures primarily involved pump malfunction and auto inflation of inflatable PPs, some resulting from surgical damage during transplant-related revisions [7]. Even successful implantations were not followed up with assessments of patients' sexual satisfaction or quality of life [7]. As such, Territo A. et al. concluded that although there is a non-negligible incidence of post-operative complications, PP implantation remains a valid option for organ transplant recipients for treating men with severe ED [7].
urology & nephrology